Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: An update

Brazilian Journal of Medical and Biological Research

Volumn 44, Issue 9, 2011, Pages 920-932

  Davel, A P ^b   Wenceslau, C F ^a   Akamine, E H ^a   Xavier, F E ^c   Couto, G K ^a   Oliveira, H T ^a   Rossoni, L V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c DEPARTAMENTO DE MICOLOGIA   (Brazil)

Author keywords

Diabetes; Endothelial dysfunction; Hypertension; Obesity; Sympathetic hyperactivity

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PROSTAGLANDIN SYNTHASE;

BIOAVAILABILITY; DEVELOPING COUNTRY; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; METABOLIC DISORDER; MORTALITY; NONHUMAN; OBESITY; REVIEW;

ANIMALIA;

EID: 80053331729     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2011007500104     Document Type: Review

References (60)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
2. Rapoport RM, Draznin MB, Murad F. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature 1983; 306: 174-176.
3. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987; 84: 9265-9269.
4. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-666.
5. Alp NJ, Channon KM. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 2004; 24: 413-420.
6. Ministério da Saúde. Portal da Saúde. http://portal.saude.gov.br/portal/aplicacoes/noticias/default.cfm?pg=dspDetalheNoticia&id_area=124&CO_NOTICIA=11290. Accessed April 1, 2011.
7. Konishi M, Su C. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 1983; 5: 881-886.
8. Xavier FE, Davel AP, Fukuda LE, Rossoni LV. Chronic ouabain treatment exacerbates blood pressure elevation in spontaneously hypertensive rats: the role of vascular mechanisms. J Hypertens 2009; 27: 1233-1242.
9. Wenceslau CF, Davel AP, Xavier FE, Rossoni LV. Long-term ouabain treatment impairs vascular function in resistance arteries. J Vasc Res 2011; 48: 316-326.
10. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993; 21: 929-933.
11. Koller A, Huang A. Impaired nitric oxide-mediated flowinduced dilation in arterioles of spontaneously hypertensive rats. Circ Res 1994; 74: 416-421.
12. Zalba G, Beaumont FJ, San Jose G, Fortuno A, Fortuno MA, Etayo JC, et al. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 2000; 35: 1055-1061.
13. +-ATPase in ouabain-induced hypertension. Br J Pharmacol 2002; 135: 771-781.
14. Rossoni LV, Salaices M, Miguel M, Briones AM, Barker LA, Vassallo DV, et al. Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors. Am J Physiol Heart Circ Physiol 2002; 283: H2110-H2118.
15. Xavier FE, Yogi A, Callera GE, Tostes RC, Alvarez Y, Salaices M, et al. Contribution of the endothelin and renin-angiotensin systems to the vascular changes in rats chronically treated with ouabain. Br J Pharmacol 2004; 143: 794-802.
16. Xavier FE, Rossoni LV, Alonso MJ, Balfagon G, Vassallo DV, Salaices M. Ouabain-induced hypertension alters the participation of endothelial factors in alpha-adrenergic responses differently in rat resistance and conductance mesenteric arteries. Br J Pharmacol 2004; 143: 215-225.
17. Somers MJ, Mavromatis K, Galis ZS, Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 2000; 101: 1722-1728.
18. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 2004; 44: 248-252.
19. Forstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 2010; 459: 923-939.
20. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003; 111: 1201-1209.
21. Luscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 1986; 8: 344-348.
22. Gluais P, Paysant J, Badier-Commander C, Verbeuren T, Vanhoutte PM, Feletou M. In SHR aorta, calcium ionophore A-23187 releases prostacyclin and thromboxane A2 as endothelium-derived contracting factors. Am J Physiol Heart Circ Physiol 2006; 291: H2255-H2264.
23. Lang MG, Noll G, Luscher TF. Effect of aging and hypertension on contractility of resistance arteries: modulation by endothelial factors. Am J Physiol 1995; 269: H837-H844.
24. Adeagbo AS, Zhang X, Patel D, Joshua IG, Wang Y, Sun X, et al. Cyclo-oxygenase-2, endothelium and aortic reactivity during deoxycorticosterone acetate salt-induced hypertension. J Hypertens 2005; 23: 1025-1036.
25. Barretto AC, Santos AC, Munhoz R, Rondon MU, Franco FG, Trombetta IC, et al. Increased muscle sympathetic nerve activity predicts mortality in heart failure patients. Int J Cardiol 2009; 135: 302-307.
26. Santos AC, Alves MJ, Rondon MU, Barretto AC, Middlekauff HR, Negrao CE. Sympathetic activation restrains endothelium-mediated muscle vasodilatation in heart failure patients. Am J Physiol Heart Circ Physiol 2005; 289: H593-H599.
27. Teerlink JR, Clozel M, Fischli W, Clozel JP. Temporal evolution of endothelial dysfunction in a rat model of chronic heart failure. J Am Coll Cardiol 1993; 22: 615-620.
28. Bauersachs J, Bouloumie A, Fraccarollo D, Hu K, Busse R, Ertl G. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation 1999; 100: 292-298.
29. Sartorio CL, Fraccarollo D, Galuppo P, Leutke M, Ertl G, Stefanon I, et al. Mineralocorticoid receptor blockade improves vasomotor dysfunction and vascular oxidative stress early after myocardial infarction. Hypertension 2007; 50: 919-925.
30. Schafer A, Fraccarollo D, Tas P, Schmidt I, Ertl G, Bauersachs J. Endothelial dysfunction in congestive heart failure: ACE inhibition vs angiotensin II antagonism. Eur J Heart Fail 2004; 6: 151-159.
31. Davel AP, Kawamoto EM, Scavone C, Vassallo DV, Rossoni LV. Changes in vascular reactivity following administration of isoproterenol for 1 week: a role for endothelial modulation. Br J Pharmacol 2006; 148: 629-639.
32. Fukuda LE, Davel AP, Verissimo-Filho S, Lopes LR, Cachofeiro V, Lahera V, et al. Fenofibrate and pioglitazone do not ameliorate the altered vascular reactivity in aorta of isoproterenol-treated rats. J Cardiovasc Pharmacol 2008; 52: 413-421.
33. Ferro A, Queen LR, Priest RM, Xu B, Ritter JM, Poston L, et al. Activation of nitric oxide synthase by beta 2-adrenoceptors in human umbilical vein endothelium in vitro. Br J Pharmacol 1999; 126: 1872-1880.
34. Jimenez-Altayo F, Briones AM, Giraldo J, Planas AM, Salaices M, Vila E. Increased superoxide anion production by interleukin-1beta impairs nitric oxide-mediated relaxation in resistance arteries. J Pharmacol Exp Ther 2006; 316: 42-52.
35. Davel AP, Fukuda LE, De Sa LL, Munhoz CD, Scavone C, Sanz-Rosa D, et al. Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta. Am J Physiol Heart Circ Physiol 2008; 295: H211-H219.
36. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-1276.
37. Pieper GM. Enhanced, unaltered and impaired nitric oxidemediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia 1999; 42: 204-213.
38. Davel AP, Rossoni LV, Vassallo DV. Effects of ouabain on the pressor response to phenylephrine and on the sodium pump activity in diabetic rats. Eur J Pharmacol 2000; 406: 419-427.
39. Akamine EH, Kawamoto EM, Scavone C, Nigro D, Carvalho MH, de Cassia AT, et al. Correction of endothelial dysfunction in diabetic female rats by tetrahydrobiopterin and chronic insulin. J Vasc Res 2006; 43: 309-320.
40. Abebe W, MacLeod KM. Protein kinase C-mediated contractile responses of arteries from diabetic rats. Br J Pharmacol 1990; 101: 465-471.
41. Xavier FE, Davel AP, Rossoni LV, Vassallo DV. Time-dependent hyperreactivity to phenylephrine in aorta from untreated diabetic rats: role of prostanoids and calcium mobilization. Vascul Pharmacol 2003; 40: 67-76.
42. Cohen RA, Tong X. Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease. J Cardiovasc Pharmacol 2010; 55: 308-316.
43. Chan NN, Vallance P, Colhoun HM. Endothelium-dependent and-independent vascular dysfunction in type 1 diabetes: role of conventional risk factors, sex, and glycemic control. Arterioscler Thromb Vasc Biol 2003; 23: 1048-1054.
44. Gimeno AL, Sterin-Borda L, Borda ES, del Castillo EJ, Gimeno MF. Arachidonate evokes constriction of coronary and mesenteric arteries isolated from diabetic dogs. Adv Prostaglandin Thromboxane Leukot Res 1983; 12: 235-240.
45. Bagi Z, Erdei N, Papp Z, Edes I, Koller A. Up-regulation of vascular cyclooxygenase-2 in diabetes mellitus. Pharmacol Rep 2006; 58 (Suppl): 52-56.
46. Tesfamariam B, Brown ML, Deykin D, Cohen RA. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 1990; 85: 929-932.
47. Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, et al. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 2003; 107: 1017-1023.
48. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
49. +-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest 1995; 96: 733-740.
50. +-ATPase activity in aortas from diabetic rats: The role of prostanoids and protein kinase C. Life Sci 2010; 87: 302-308.
51. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001; 280: E685-E694.
52. Sturm W, Sandhofer A, Engl J, Laimer M, Molnar C, Kaser S, et al. Influence of visceral obesity and liver fat on vascular structure and function in obese subjects. Obesity 2009; 17: 1783-1788.
53. Eringa EC, Bakker W, Smulders YM, Serne EH, Yudkin JS, Stehouwer CD. Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Microcirculation 2007; 14: 389-402.
54. Kobayasi R, Akamine EH, Davel AP, Rodrigues MA, Carvalho CR, Rossoni LV. Oxidative stress and inflammatory mediators contribute to endothelial dysfunction in high-fat diet-induced obesity in mice. J Hypertens 2010; 28: 2111-2119.
55. Kralisch S, Sommer G, Stangl V, Kohler U, Kratzsch J, Stepan H, et al. Secretory products from human adipocytes impair endothelial function via nuclear factor kappaB. Atherosclerosis 2008; 196: 523-531.
56. Zecchin HG, Priviero FB, Souza CT, Zecchin KG, Prada PO, Carvalheira JB, et al. Defective insulin and acetylcholine induction of endothelial cell-nitric oxide synthase through insulin receptor substrate/Akt signaling pathway in aorta of obese rats. Diabetes 2007; 56: 1014-1024.
57. Lobato NS, Filgueira FP, Akamine EH, Davel AP, Rossoni LV, Tostes RC, et al. Obesity induced by neonatal treatment with monosodium glutamate impairs microvascular reactivity in adult rats: Role of NO and prostanoids. Nutr Metab Cardiovasc Dis 2010 [doi: 10.1016/j.numecd.2010.02.006].
58. Yang N, Ying C, Xu M, Zuo X, Ye X, Liu L, et al. High-fat diet up-regulates caveolin-1 expression in aorta of diet-induced obese but not in diet-resistant rats. Cardiovasc Res 2007; 76: 167-174.
59. Sanchez A, Contreras C, Martinez P, Villalba N, Benedito S, Garcia-Sacristan A, et al. Enhanced cyclooxygenase 2-mediated vasorelaxation in coronary arteries from insulinresistant obese Zucker rats. Atherosclerosis 2010; 213: 392-399.
60. Pierce GL, Lesniewski LA, Lawson BR, Beske SD, Seals DR. Nuclear factor-{kappa}B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/ obese middle-aged and older humans. Circulation 2009; 119: 1284-1292.